These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 12502878

  • 1. The high-risk human papillomavirus type 16 E6 counters the GAP function of E6TP1 toward small Rap G proteins.
    Singh L, Gao Q, Kumar A, Gotoh T, Wazer DE, Band H, Feig LA, Band V.
    J Virol; 2003 Jan; 77(2):1614-20. PubMed ID: 12502878
    [Abstract] [Full Text] [Related]

  • 2. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
    Gao Q, Kumar A, Singh L, Huibregtse JM, Beaudenon S, Srinivasan S, Wazer DE, Band H, Band V.
    Cancer Res; 2002 Jun 01; 62(11):3315-21. PubMed ID: 12036950
    [Abstract] [Full Text] [Related]

  • 3. The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation.
    Gao Q, Srinivasan S, Boyer SN, Wazer DE, Band V.
    Mol Cell Biol; 1999 Jan 01; 19(1):733-44. PubMed ID: 9858596
    [Abstract] [Full Text] [Related]

  • 4. Human papillomavirus type 16 E6-induced degradation of E6TP1 correlates with its ability to immortalize human mammary epithelial cells.
    Gao Q, Singh L, Kumar A, Srinivasan S, Wazer DE, Band V.
    J Virol; 2001 May 01; 75(9):4459-66. PubMed ID: 11287601
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase.
    Pim D, Thomas M, Javier R, Gardiol D, Banks L.
    Oncogene; 2000 Feb 10; 19(6):719-25. PubMed ID: 10698489
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human papillomavirus type 16 E6 protein interacts with cystic fibrosis transmembrane regulator-associated ligand and promotes E6-associated protein-mediated ubiquitination and proteasomal degradation.
    Jeong KW, Kim HZ, Kim S, Kim YS, Choe J.
    Oncogene; 2007 Jan 25; 26(4):487-99. PubMed ID: 16878151
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
    Poirson J, Biquand E, Straub ML, Cassonnet P, Nominé Y, Jones L, van der Werf S, Travé G, Zanier K, Jacob Y, Demeret C, Masson M.
    FEBS J; 2017 Oct 25; 284(19):3171-3201. PubMed ID: 28786561
    [Abstract] [Full Text] [Related]

  • 12. A Wnt-CKIvarepsilon-Rap1 pathway regulates gastrulation by modulating SIPA1L1, a Rap GTPase activating protein.
    Tsai IC, Amack JD, Gao ZH, Band V, Yost HJ, Virshup DM.
    Dev Cell; 2007 Mar 25; 12(3):335-47. PubMed ID: 17336901
    [Abstract] [Full Text] [Related]

  • 13. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T, Boutati E, Pectasides E, Sasaki C, Kountourakis P, Weinberger P, Psyrri A.
    Mol Cancer Res; 2010 Mar 25; 8(3):433-43. PubMed ID: 20215420
    [Abstract] [Full Text] [Related]

  • 14. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
    Massimi P, Shai A, Lambert P, Banks L.
    Oncogene; 2008 Mar 13; 27(12):1800-4. PubMed ID: 17934525
    [Abstract] [Full Text] [Related]

  • 15. NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.
    Katzenellenbogen RA, Egelkrout EM, Vliet-Gregg P, Gewin LC, Gafken PR, Galloway DA.
    J Virol; 2007 Apr 13; 81(8):3786-96. PubMed ID: 17267499
    [Abstract] [Full Text] [Related]

  • 16. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
    Jung YS, Kato I, Kim HR.
    Biochem Biophys Res Commun; 2013 Jun 07; 435(3):339-44. PubMed ID: 23628416
    [Abstract] [Full Text] [Related]

  • 17. Purification of a plasma membrane-associated GTPase-activating protein specific for rap1/Krev-1 from HL60 cells.
    Polakis PG, Rubinfeld B, Evans T, McCormick F.
    Proc Natl Acad Sci U S A; 1991 Jan 01; 88(1):239-43. PubMed ID: 1846040
    [Abstract] [Full Text] [Related]

  • 18. Complexes of human papillomavirus type 16 E6 proteins form pseudo-death-inducing signaling complex structures during tumor necrosis factor-mediated apoptosis.
    Filippova M, Filippov VA, Kagoda M, Garnett T, Fodor N, Duerksen-Hughes PJ.
    J Virol; 2009 Jan 01; 83(1):210-27. PubMed ID: 18842714
    [Abstract] [Full Text] [Related]

  • 19. HPV16 E6 Controls the Gap Junction Protein Cx43 in Cervical Tumour Cells.
    Sun P, Dong L, MacDonald AI, Akbari S, Edward M, Hodgins MB, Johnstone SR, Graham SV.
    Viruses; 2015 Oct 05; 7(10):5243-56. PubMed ID: 26445057
    [Abstract] [Full Text] [Related]

  • 20. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T, Fournane S, Orfanoudakis G, Travé G, Masson M.
    Oncogene; 2009 Feb 05; 28(5):762-72. PubMed ID: 19015633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.